Imexpharm Corp (IMP) — Cash Flow Reinvestment Rate
Latest as of March 2026:
0.08x
Imexpharm Corp (IMP) has a Cash Flow Reinvestment Rate of 0.08x as of March 2026, reinvesting ₫7.79 Billion (capex ₫7.79 Billion ) from operating cash flow of ₫103.49 Billion. Explore Imexpharm Corp capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.08x
(Capex + Investments) / Operating CF
Total Reinvested
₫7.79 Billion
Capex + Investments
Operating Cash Flow
₫103.49 Billion
VND
Capital Expenditures
₫7.79 Billion
VND
Imexpharm Corp Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Imexpharm Corp across 6 annual periods. Also explore balance sheet size of Imexpharm Corp for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Imexpharm Corp (2019–2025)
Year-by-year capital reinvestment analysis for Imexpharm Corp. For live market cap and broader valuation context, see IMP market cap overview.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | ₫26.88 Billion | ₫54.17 Billion | ₫26.88 Billion | ▼ -52.1% |
| 2024 | 1.04x | ₫223.97 Billion | ₫216.27 Billion | ₫96.77 Billion | ▲ +31.3% |
| 2022 | 0.79x | ₫298.66 Billion | ₫378.60 Billion | ₫99.35 Billion | ▼ -37.8% |
| 2021 | 1.27x | ₫297.80 Billion | ₫234.88 Billion | ₫52.86 Billion | ▼ -52.6% |
| 2020 | 2.67x | ₫195.62 Billion | ₫73.15 Billion | ₫89.68 Billion | ▲ +9.1% |
| 2019 | 2.45x | ₫163.21 Billion | ₫66.59 Billion | ₫131.12 Billion | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow